A 67-year-old patient died of Legionella bozemanii pneumonia with negative urinary antigen and negative serology. Cystic lesions in pneumonia of unknown origin should lead to the differential diagnosis of L. bozemanii infections.
ing ICU stay. Despite broad-spectrum antimicrobial and corticosteroid therapy, clinical signs and symptoms deteriorated, CRP and WBC rose, and thrombocytes dropped. One day later, the patient required emergency intubation because of acute respiratory distress syndrome (ARDS). CRP was 325 mg/l, WBC 18 × 10 9 /l. A CT scan continued to reveal progressing infiltrates in both lungs. A bronchial aspirate grew one colony of Aspergillus fumigatus that was interpreted as contamination. Antibiotics were switched from P/T to meropenem due to continuous deterioration of the clinical status. Severe thrombocytopenia of unknown etiology delayed lung biopsy for 4 weeks, which demonstrated interstitial fibrosing pneumonia with accumulation of intra-alveolar foamy macrophages. Few colonies of A. fumigatus grew from biopsy material suggesting pulmonary invasive aspergillosis. Therefore, liposomal amphotericin B was added. Despite broad-spectrum antimicrobial therapy, respiratory failure developed. On repeat chest Xray and CT scan, new cavitary lesions became prominent in the right upper lobe. Because the histology of the lung did not show any signs of invasive aspergillosis, cyclosposphamid was added for possible necrotising pulmonary vasculitis. A repeated urinary antigen test and a serology for Legionella pneumophila (Legionella pneumophila [1] [2] [3] [4] [5] [6] [7] [8] IFA, Meridian Bioscience, Cincinnati, OH, USA) remained negative. However, L. bozemanii grew from cultures of the lung biopsy and Dieterle stain demonstrated intra-and extracellular rods (Figure 1 ). Clarithromycin was reestablished, but the patient deceased 2 days later after start of treatment. Identification of the strain was confirmed by the Swiss Legionella reference laboratory. The source of L. bozemanii remained unknown: samples from hospital faucets and from the shower and faucets of patient's home proved negative for Legionella spp.
L. bozemanii is an infrequent cause of legionellosis, even though endemic in water and soil, also in Europe. L. bozemanii infections in immunocompromised patients typically produce cavitary lung lesions [3, 4] .
Immunocompromised patients with cystic lesions in the upper lobes frequently suffer from tuberculosis, but other diagnoses should be considered such invasive aspergillosis or an autoimmune disease [5] . Clinicians should be aware on recent reports from patients after transplantation or AIDS with L. bozemanii infections [3, 6] . Diagnosis of L. bozemanii is difficult: commonly used urinary antigen tests for Legionella and serological kits fail to consistently detect L. bozemanii [7] . The urinary antigen for Legionella is targeted against L. pneumophila serotype 1, and was repetitively negative in the present case, challenging a recent report [8] . None of the commercially available serological kits are able to identify antibodies to L. bozemanii with high sensitivity and remained negative in this case. Even microbiologic cultures using media for Legionella may be false negative since most culture media for Legionella contain cefamandole, a drug being active against L. bozemanii in vitro [9] in contrast to other species of Legionella.
L. bozemanii should be included in the differential diagnosis of cystic lung lesions in the lower lobes, when more frequently observed diagnoses such as tuberculosis and non-infectious diseases have been ruled out [10] . Appropriate specimens with specific information to the microbiology laboratory are crucial to isolate L. bozemanii. Lung biopsies should be investigated for Legionella e.g., by the Dieterle stain in cystic lesions of unknown origin. Today, antimicrobial treatment with a quinolone may be preferred to macrolides in the immunocompromised host [5, 11, 12] . In conclusion, clinical awareness of this rare pathogen and an interdisciplinary approach to immunocompromised patients presenting with cavitary pneumonia of unknown origin are crucial for guided treatment to decrease mortality of this severe disease. Diagnosis of L. pneumophila serogroup 1 has been facilitated by the rapid urinary antigen test. However, only cultures for Legionella are able to detect other Legionella species and should not be abandoned, particularly in severely ill patients. 
